StockWatch
·
Trading & Distributors
Quarterly Updates30 May 2026, 07:52 pm

Evoq Remedies Reports FY26 Results; Qualified Opinion

AI Summary

Evoq Remedies Ltd submitted integrated financial results for the half year and year ended March 31, 2026. The auditor's report expresses a qualified opinion with material uncertainty related to going concern. The audit highlights non-compliance with provisions governing related party loans, specifically Sections 177, 185, 188, and 189 of the Companies Act, 2013, read with Accounting Standard 18. Loans aggregating ₹670.26 lakhs were extended to related parties without prior audit committee approval, violating prescribed conditions and thresholds.

Key Highlights

  • Evoq Remedies' FY26 results come with a qualified audit opinion.
  • Auditor notes material uncertainty related to the company's going concern.
  • Company violated Sections 177, 185, 188, and 189 of Companies Act regarding related party loans.
  • ₹670.26 lakhs in loans extended to related parties without audit committee approval.